Norman Douglas Deen Jr, | |
1115 Weber St, Franklin, LA 70538-4124 | |
(337) 828-2550 | |
Not Available |
Full Name | Norman Douglas Deen Jr |
---|---|
Gender | Male |
Speciality | Physician Assistant |
Location | 1115 Weber St, Franklin, Louisiana |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417681024 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363A00000X | Physician Assistant | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Norman Douglas Deen Jr, 5850 E Still Cir, Mesa, AZ 85206-3618 Ph: (480) 219-6000 | Norman Douglas Deen Jr, 1115 Weber St, Franklin, LA 70538-4124 Ph: (337) 828-2550 |
News Archive
ArborGen Inc., the world's leading developer of biotechnology tree seedling products and one of the largest providers of conventional and technology-enhanced seedlings to the global commercial forestry industry, announced today that it has filed a registration statement with the Securities and Exchange Commission relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the offering have not yet been determined.
University of Manchester scientists have identified a gene - FOXC1 - that, if switched on, causes more aggressive cancer in a fifth of acute myeloid leukaemia (AML) patients, according to a Cancer Research UK study published in the journal Cancer Cell, today (Monday).
Researchers conducted a prospective randomized controlled clinical trial at Bern University Hospital in Switzerland to compare a laparoscopic procedure with a mini-laparotomy for insertion of a peritoneal catheter during ventriculoperitoneal (VP) shunt surgery. The deciding factor was the rate of shunt malfunction.
The discovery of an unusual hepatitis B virus from shrews offers new opportunities of better understanding the chronic progression of the disease. International research teams were able to demonstrate that an important protein which is essential for the development of a chronic course of infection is not present in this virus.
Myriad Pharmaceuticals, Inc. today announced the presentation of clinical data from two separate Phase 2a combination drug studies of AzixaTM (MPC-6827, verubulin) at the American Society of Clinical Oncology 2010 Annual Meeting in Chicago, IL. Results from studies in both recurrent glioblastoma multiforme and stage 4 metastatic melanoma demonstrated that Azixa, in combination with standard treatments, resulted in durable responses with no added toxicity compared with chemotherapy alone.
› Verified 3 days ago
Kira Leigh Ridgley, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1105 Northwest Blvd., Franklin, LA 70538 Phone: 337-907-6338 | |
Mrs. Claire Curry Barnett, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1501 Bethia St, Franklin, LA 70538 Phone: 337-828-3507 | |
Mrs. Natalyn Sonnier Fontenot, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 603 Haifleigh St, Franklin, LA 70538 Phone: 337-828-9092 Fax: 337-828-3945 | |
Eden Desiree Etcheverria, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1115 Weber St, Franklin, LA 70538 Phone: 337-828-2550 Fax: 337-355-2332 | |
Wilfred Broussard, P.AP Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1115 Weber St, Franklin, LA 70538 Phone: 337-828-2550 Fax: 337-355-2335 |